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Culture of cells using various microﬂuidic devices is becoming more common within experimental cell
biology. At the same time, a technological radiation of microﬂuidic cell culture device designs is currently
in progress. Ultimately, the utility of microﬂuidic cell culture will be determined by its capacity to permit
new insights into cellular function. Especially insights that would otherwise be difﬁcult or impossible to
obtain with macroscopic cell culture in traditional polystyrene dishes, ﬂasks or well-plates. Many
decades of heuristic optimization have gone into perfecting conventional cell culture devices and
protocols. In comparison, even for the most commonly used microﬂuidic cell culture devices, such as
those fabricated from polydimethylsiloxane (PDMS), collective understanding of the differences in
cellular behavior between microﬂuidic and macroscopic culture is still developing. Moving in vitro
culture from macroscopic culture to PDMS based devices can come with unforeseen challenges. Changes
in device material, surface coating, cell number per unit surface area or per unit media volume may all
affect the outcome of otherwise standard protocols. In this review, we outline some of the advantages
and challenges that may accompany a transition from macroscopic to microﬂuidic cell culture. We focus
on decisive factors that distinguish macroscopic from microﬂuidic cell culture to encourage a
reconsideration of how macroscopic cell culture principles might apply to microﬂuidic cell culture.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-SA license
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.T. Fleming).1. Introduction
Microﬂuidics refers to a set of technologies for the manipula-
tion of small ﬂuid volumes (mL, nL, pL), within artiﬁcially fabricated
microsystems (Whitesides, 2006). Microﬂuidic systems enablender the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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and parallelization of (bio-)chemical processes (Mark et al., 2010).
The application of microﬂuidics to biology and medicine has lead
to a diversity of new research directions (Melin and Quake, 2007;
Yeo et al., 2011), some of which have had signiﬁcant impact
(Sackmann et al., 2014). Cell culture refers to the maintenance
and growth of cells in a controlled laboratory environment. Such
in vitro cell culture models are the mainstay of experimental cell
biological research. Microﬂuidic cell culture attempts to develop
devices and techniques for culturing, maintaining, analyzing and
experimenting with cells in micro-scale volumes (Meyvantsson
and Beebe, 2008).
Understanding the interplay between critical cell culture para-
meters and the microenvironmental conditions created by micro-
ﬂuidic devices will accelerate the development of microﬂuidic cell
culture technology (Sackmann et al., 2014). Some important
aspects of microﬂuidic cell culture systems have previously been
reviewed, including the effect of surface modiﬁcation on cellular
behavior (Zhou et al., 2012), cell biology (Paguirigan and Beebe,
2008; Salieb-Beugelaar et al., 2010), cell culture models
(Meyvantsson and Beebe, 2008), cellular analysis (Park and Shuler,
2003; Yeo et al., 2011), cellular microenvironment (Meyvantsson
and Beebe, 2008; Young and Beebe, 2010), cell secretion (Huang
et al., 2011), chemotaxis (Kim and Wu, 2012), apoptosis
(Wlodkowic et al., 2011), vascular function (Wong and Chan,
2012), neuroscience in general (Soe et al., 2012), in particular
neuron culture (Millet and Gillette, 2012) and development
(Millet and Gillette, 2012), single cell resolution metabolomics
(Rubakhin et al., 2011), population transcriptomics (Plessy et al.,
2013), lab-on-chip platforms (Mark et al., 2010; Ni et al., 2009),
large-scale integration and biological automation (Melin and
Quake, 2007), micro total analysis systems (Kovarik et al., 2012),
drug research (Wu et al., 2010), cellular separations (Bhagat et al.,Fig. 1. Overview of advantages and challenges of b2010), stem cell biology (Wu et al., 2011), system biology
(Breslauer et al., 2006), bioreactors (Pasirayi et al., 2011), three
dimensional cell culture (Haycock, 2011), tissue engineering
(Inamdar and Borenstein, 2011), and efforts toward organs-on-chip
(Huh et al., 2011).
Complementing the aforementioned reviews, the present
review is aimed at researchers familiar with conventional/macro-
scopic cell culture, who are considering microﬂuidic cell culture
for the ﬁrst time. This review focuses on the practicalities of
microﬂuidic cell culture and some advantages it may hold over
macroscopic cell culture, but also the challenges that may accom-
pany the culture of cells using a microﬂuidic device. Decisive
factors are discussed that distinguish macroscopic from micro-
ﬂuidic cell culture. The overall aim is to give the reader a better
understanding of the rewards and challenges that microﬂuidic cell
culture can bring.2. Advantages of microﬂuidic cell culture
Microﬂuidic cell culture has signiﬁcant advantages over macro-
scopic culture, that is, culture in ﬂasks, dishes and well-plates.
Fig. 1 describes the most signiﬁcant advantages and challenges
when using macroscopic versus microﬂuidic cell culture. There is
great ﬂexibility in the design of microﬂuidic devices, which can be
tailored to the needs of individual cell types and cellular co-
cultures can be implemented on the same chip (Yeo et al., 2011).
The advantages of microﬂuidic cell culture include the ability to
more closely mimic a cell's natural microenvironment, for example
by continuous perfusion culture or by creating chemical gradients,
and to study low numbers of cells or single cells in high temporal
and/or spatial resolution via automation, parallelization, on-chip
analysis or direct coupling to downstream analytical chemistryoth macroscopic and microﬂuidic cell culture.
Table 1
Comparative analysis of advantages on reported studies using microﬂuidic cell culture (Poss¼possible, N/C¼Not Clear).
Advantages Migration
mechanisms
Biochemical
stimulation
Metabolic analysis Toxicity assay High throughput Diverse cell types Cell-cell interactions
Huang
et al.
(2011)
Vedel
et al.
(2013)
Bianco
et al.
(2012)
Bifﬁ et al.
(2012)
Croushore
et al. (2012)
Shintu
et al.
(2012)
Gao et al.
(2012)
Cooksey
et al. (2011)
Gomez-
Sjoberg et al.
(2007)
Lecault
et al.
(2011)
Grossmann
et al. (2011)
Antia
et al.
(2007)
Zheng
et al.
(2012)
Hong
et al.
(2012)
Ramadan
et al. (2013)
Low sample/reagent
usage
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Experimental
resolution
Yes Yes Yes Yes Yes N/C Yes Yes Yes Yes Yes Yes Yes Yes Yes
Flexibility of device
design
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Single cell handling Yes Poss Poss No No No Poss Poss Poss Poss No Poss Poss Yes No
High experimental
control
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Poss Yes Yes Yes Yes
On-chip analysis Yes Yes Yes Yes N/C Yes Yes Yes Yes Yes Yes Poss Yes Yes Yes
Real-time data
acquisition
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Culture under
perfusion
N/C Poss No Yes Poss Yes Poss Yes Poss Poss Yes Yes Yes Yes Yes
Downstream analytical
tools
N/C Poss Yes Yes Yes N/C Yes Poss Poss N/C Poss N/C N/C N/C N/C
Automation Yes Yes Poss Poss Yes Poss Poss Yes Yes Yes Yes Poss Yes Yes Yes
High throughput
capabilities
No Yes No No No No Yes Yes Yes Yes Yes No Yes Yes Poss
Co-culture with other
cells
No Poss Yes No No No No No Poss No No Poss Yes Yes Yes
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reduced consumption of reagents, reduced contamination risk and
efﬁcient high throughput experimentation. Table 1 presents a
comparative analysis of the advantages of microﬂuidic cell culture
and selected publications that exploit those advantages.
Macroscopic cell cultures typically contain 104–107 cells, with
ﬂuid measurements representing the average over a large group of
cells. This inevitably evens out some of the inherent heterogeneity
within a cell population. Microﬂuidic cell culture devices bring the
cell population down to a few hundred cells, or even a single cell,
making it possible to capture perturbations to individual cells,
increasing the spatial and temporal resolution for a given experi-
mental setup. For instance, the thermodynamic, kinetic and
mechanical characteristics of cell locomotion (protrusion, attach-
ment and translocation) can be better understood with experi-
ments performed at single cell resolution (Lauffenburger and
Horwitz, 1996; Nishimura et al., 2009). Macroscopic methods used
to study cell migration processes include the Boyden chamber and
scratch or wound-healing assays (Liang et al., 2007). These
methods lack the single cell resolution required to better under-
stand the process of cell locomotion. These methods are relatively
easy to set up and can somewhat reﬂect the migratory behavior of
cells in vivo when performed within a live-cell imaging station.
However, they are time consuming, larger amount of cells are
required, and chemical gradients cannot be established (Liang
et al., 2007; van der Meer et al., 2010).
Microﬂuidic cell culture offers an alternative to macroscopic
methods to study cell migration processes and their mechanisms
at single cell resolution. Taking into consideration the advantages
of design ﬂexibility, the ability to handle single cells for experi-
mentation, real-time on-chip analysis via time-lapse microscopy
and low reagent consumption. Huang et al. (2011) developed a
compartmentalized microﬂuidic cell culture device which resem-
bles the physiological environment of migrating cells. They char-
acterized cellular locomotion mechanisms and cell morphology
during brain tumor stem cell migration by resolving the behavior
of individual cells. For instance, migrating stem cells display
morphological polarization, membrane extension, formation and
stabilization of attachments, contractile force and traction, and
release of attachments. This platform can be tailored to study
migration at the single cell level, providing superior experimental
resolution over macroscopic cell migration assays, such as the
wound-healing assay.
Microﬂuidic cell culture devices also make it feasible to study
complex cellular behavior, like the relationship between single cell
movements and collective cell migration. For example, Vedel et al.
(2013) studied the role played by collective cellular interactions on
cell motility at different cellular densities within a microﬂuidic
device. Single cell locomotive behavior (straight lines, curved
paths and short distances with no directionality), speed distribution
and pseudopodia formation were quantiﬁed. By capturing sufﬁ-
cient data on the locomotion of individual cells within culture
chambers with independently varied conditions, these authors
developed a mathematical model to predict the role of social
interaction in motility.
Microﬂuidic devices offer the advantages of precise control
over experimental conditions via custom designed chip architec-
tures, parallelization, automation, and direct coupling to miniatur-
ized downstream analysis platforms. This, so-called lab-on-a-chip,
versatility has been exploited in neuroscience research, mainly for
studies concerning cellular and molecular neurobiology, cellular
electrophysiology and neurodegenerative diseases (Soe et al.,
2012). In comparison with macroscopic neuronal cell culture
methodologies like hanging drop, Carrel ﬂask, slide chamber,
Campenot chamber and brain slice chamber, the chemiotemporal
and spatial control over the cellular microenvironment is limited(Millet and Gillette, 2012; Kovarik et al., 2012). Microﬂuidic cell
culture can overcome some of these drawbacks as it is possible to
culture networks formed by small numbers of neuronal and non-
neuronal cells seeded in prescribed patterns. This allows for more
control over the extracellular microenvironment, monitoring of
communication between cells and spatiotemporally localized
stimulation. For instance, Bianco et al. (2012) developed an over-
ﬂow microﬂuidic network system, operated in open and closed
conﬁgurations, to culture primary neurons. This system was used
to study the inﬂuence of astrocytes, derived from different regions
of the brain, on the viability of neurons precisely supplied with
stimulant molecules. Immunocytochemical staining, quantitative
intracellular calcium imaging and electrophysiological recording
were also integrated into the system. In order to study biochemical
stimulation of neuronal networks, Bifﬁ et al. (2012) developed a
microﬂuidic system consisting of a dual channel conﬁguration
with micro chambers for the culture and drug stimulation of
spatially and temporally controlled neuronal networks. This device
reduced the experimental variability and the time of experimenta-
tion, bringing considerable improvements over macroscopic meth-
ods. Recently, Robertson et al. (2014) developed a microﬂuidic
device to culture primary hippocampal neurons in adjacent
chambers that were individually fed through inlet and outlet ports
and synaptically connected via microchannels through a barrier
that prevented exchange of extracellular ﬂuid between the two
chambers. Using calcium imaging, they measured electrophysio-
logical communication between neurons in separate chambers in
response to stimulation of neurons in one chamber with KCL and
glutamate, revealing how the activity of one hippocampal neuro-
nal network is modulated by changes in the activity of a second
network.
An advantage of microﬂuidic cell culture is the ability to
incorporate analytical biosensors into the culture platform, thus
combining living cells and sensors for detection of cellular phy-
siological parameters and analysis of external stimuli in situ, in a
non-invasive way (Liu et al., 2014). These biosensors can provide
rapid and sensitive analysis based on a small number of cells and
low reagent volumes. In metabolomics, highly reproducible quan-
tiﬁcation is desired (Verpoorte et al., 2010). Metabolomic protocols
for macroscopic cell culture samples require several experimental
steps that are usually completed as separate operations. Sample
preparation requires efﬁcient cell lysis and optimal analyte extrac-
tion with minimal dilution. Sample measurement requires high
resolution separation techniques and sensitive detection. Micro-
ﬂuidic systems have the potential to integrate cell culture with the
aforementioned analytical chemistry on a single device, thereby
increasing reproducibility (Yeo et al., 2011; Rubakhin et al., 2011).
For instance, Croushore et al. (2012) assembled a microﬂuidic
system to culture bag cell neurons in a controlled microenviron-
ment. Cells were stimulated with precise doses of potassium
chloride and insulin, and released molecules were collected with
minimal dilution. The system was coupled to an off-line mass
spectrometer for neuropeptide characterization. Ges and
Baudenbacher (2010) embedded lactate sensing electrodes within
a microﬂuidic cell culture system, creating a biosensor to evaluate
anaerobic respiration in living ﬁbroblasts. Recently, Shintu et al.
(2012) integrated microﬂuidic cell culture with metabolic proﬁling
to investigate the potential of metabolic footprinting to character-
ize the response of “bio-artiﬁcial organs” to various small mole-
cules, an approach which may have the potential to be used for the
testing of toxicological responses in vitro.
Some microﬂuidic cell culture devices incorporate in situ
separation columns, which are directly coupled to mass spectro-
metry, or use electrochemical sensors and other technologies as
analytical tools. For instance, Chen et al. (2012) developed a
microﬂuidic system combining cell culture with stable isotope
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system consists of a microﬂuidic network for reagent supply, cell
culture chambers and on-chip separation micro columns for
sample pre-treatment, preceding analyte detection using mass
spectrometry. This system was used to study drug-induced apop-
tosis and perform quantitative measurements of cell metabolism
in MCF-7 cells. A similar approach was used by Gao et al. (2012).
This group created a microﬂuidic cell culture system to validate
and perform studies on the absorption of methotrexate and its
effects on HepG2 and Caco-2 cells (heterogeneous human epithe-
lial colorectal adenocarcinoma cell line), using electrospray ioniza-
tion quadrupole time-of-ﬂight mass spectrometry. To evaluate the
performance of a cell based toxicity assay using a microﬂuidic cell
culture system, Cooksey et al. (2011) studied the repeatability with
the same device, the reproducibility between devices, and the
robustness of the microﬂuidic assay to variations in cell density.
They used real time quantitative ﬂuorescence imaging to measure
green ﬂuorescent protein decay due to inhibition of ribosome
activity by cycloheximide. They found that assays performed in
microﬂuidic devices showed comparable results to macroscopic
culture assays and that microﬂuidic assays generally showed
higher levels of conﬁdence. In another study, Sugiura et al. (2010)
used a serial dilution microﬂuidic network to characterize dose
drug response of HeLa cells challenged with a mitotic inhibitor
(paclitaxel) in a microﬂuidic system. Electrochemical methods
have also being used in the detection of cellular responses in
microﬂuidic cell culture. Ges et al. (2012) used chromafﬁn cells
cultured in a microﬂuidic biosensor to quantify catecholamine
release using iridium oxide ﬁlms on platinum electrodes. Cao et al.
(2014) created a microﬂuidic cell culture perfusion chip integrated
with electrochemical sensing electrodes allowing non-invasive
and accurate estimation of proliferation and apoptosis of HeLa cell
in 3D culture in response to anticancer drugs. To evaluate the
migratory properties of breast cancer cells, Nguyen et al. (2013)
developed a microﬂuidic device integrated with cell-sensing
impedence measuring electrodes. This device allowed rapid and
sensitive detection of cell adhesion, cell spreading and cell migra-
tion at the single cell level in 2D and 3D cultures, eliminating the
need for time consuming, large cell population based experiments
such as the Boyden chamber. All these research endeavors exem-
plify some advantages in analytical control and the system design
ﬂexibility that microﬂuidic lab-on-a-chip offers when compared
with macroscopic approaches to perform the same type of studies.
Most macroscopic high throughput cell culture settings depend
on microtiter plates, together with liquid handling devices for the
delivery of cells and reagents. This increases reagent consumption
and the labor required for a given experiment. The possibility of
fabricating miniature devices with complex ﬂuidic architectures
together with the ﬂexibility of parallelization and automation,
allows for implementation of high throughput cell culture, thus
reducing the reagent consumption and labor costs. Considering
these advantages, Zhou et al. (2012) developed a liquid pipet chip
(microﬂuidic liquid handler system), for the automated delivery of
nanoliter amounts of liquid to culture cells for high throughput
screening applications. This device allowed the delivery and
change of reagents for cell manipulation experiments in a 96
micro-well format and could be integrated to a microscope for real
time data acquisition. Gomez-Sjoberg et al. (2007) developed a
microﬂuidic cell culture system with 96 individually addressable
chambers. This highly automated platform allows the surface
coating treatment with extracellular matrix (ECM) proteins of each
individual culture chamber in the microﬂuidic chip. A sequential
cell loading mechanism permits control over the number of cells
to load into each chamber, as well as the speciﬁc formulation of
reagent composition for each individual chamber. It is possible to
seed several cell lines without cross-contamination. Cell viabilityand data acquisition via time-lapse microscopy can be maintained
for weeks. This platform is ideal for use in cell culture experiments
requiring a high number of different culture conditions. Going a
step further on throughput capabilities, Lecault et al. (2011)
developed an iso-osmotic perfusion microﬂuidic cell culture device,
with a non-perturbing cell-capture mechanism that uses gravity to
trap cells and automated medium exchange. This 1600 chamber
microﬂuidic cell culture device is capable of keeping the desired
osmolarity in the culture chamber. Furthermore, non-adherent
cells are immobilized during medium exchange and viable cells
are recovered. Such devices are envisaged to be of use in colony
growth and variability studies, drug-response screens and other
applications that require high throughput cell culture.
Utilizing the ﬂexibility and ease of prototyping PDMS, it is
possible to design, mold and fabricate microﬂuidic systems with
several advantages over macroscopic systems. For instance, sys-
tems capable of sustaining a variety of cell types, under perfusion
or statically, with control over environmental parameters and real-
time data acquisition at single cell resolution. The study of root
metabolism in plants has been limited by the availability of more
versatile macroscopic root/cell culture methods, suitable experi-
mental systems, the underground nature of this organ and reliable
methods for data acquisition. Grossmann et al. (2011) developed a
generic microﬂuidic platform integrated with a live-cell imaging
station, “RootChip”, to study root cell physiology, growth, nutrient
uptake, root metabolism and signaling in A. thaliana roots. This
microﬂuidic system was speciﬁcally designed for plant culture
applications where cell-resolved assays can be performed. Perfu-
sion culture at scales typical of microvasculature would be a
challenge with macroscopic culture. Antia et al. (2007) replicated
physiological ﬂow conditions, within a microﬂuidic device, to
study the cytoadherence and rheological responses of infected red
blood cells to puriﬁed ICAM-1 and CD36. Golchin et al. (2012)
cultured single mycobacterial cells in a microﬂuidic system to
measure the molecular mechanisms of stochasticity of bacterial
persistence using time-lapse microscopy and omics analyses.
Macroscopic co-culture of cells either relies on layering differ-
ent cell types on top of each other or the use of a permeable
membrane to keep cells physically separated, while allowing
transmembrane communication (Miki et al., 2012; van Moorst
and Dass, 2011; Burguera et al., 2010). These macroscopic methods
of co-culture are being surpassed by more sophisticated micro-
ﬂuidic platforms, which allow experiments to be performed using
different types of cells at the single cell level (Chiang et al., 2013).
For instance, to quantify cell–cell interactions mediated by soluble
factors, Zheng et al. (2012) developed a fully automated micro-
ﬂuidic cell co-culture system where migration of co-cultured HeLa
and HUVEC cells was monitored at single cell resolution. Hong
et al. (2012) achieved the co-culture of single-cells that were
paired in single chambers, by using variable ﬂuidic resistance and
a sequential cell trapping mechanism. The microﬂuidic chip
contains 340 single-cell culture chambers that provide a well-
controlled physiological microenvironment to study intercellular
communications at a single cell level.
While the physiological architecture of human organs currently
exceeds the complexity of all in vitro culture systems, microﬂuidic
cell culture devices can be fabricated that capture some of this
architectural complexity. For instance, Ramadan et al. (2013)
developed a gastrointestinally motivated microﬂuidic system cap-
able of co-culture of Caco-2 cells and U937 cells (macrophage-
like). This system allows monitoring the response of immune cells
to pro-inﬂammatory stimuli under ﬂuid ﬂow conditions. Ramadan
et al. envisage this to be used as an in vitro model to study the
absorption of nutrients and immune-modulatory functions in the
human gastrointestinal tract. Lee et al. (2013) recently developed a
three dimensional microﬂuidic platform to study hepatocyte–
Table 2
Comparison of key parameters between macroscopic and microﬂuidic cell cultures.
Parameter Macroscopic culture (Polystyrene) Microﬂuidic culture (PDMS)
Physical properties Transparent Transparent
Stiff Soft, ﬂexible
Low gas permeability Very high gas permeability
Little or no absorption of molecules Absorbs small hydrophobic molecules (Wang et al., 2012).
Cell numbers Few thousand (microtiter plate) to tens of millions (large culture
ﬂask).
Single cell (Zheng et al., 2012) to a few thousand.
Volume densities Flasks, dishes and well plates generally have – μ2 4 L of medium and
100–1000 cells per mm2 of growth surface.
Varies between microﬂuidic devices but can be as high as 60 nL of medium
and 200 cells per 1 mm2 or approx. 50higher than macroscopic culture
(Gomez-Sjoberg et al., 2007).
Nutrient consumption Nutrients in cell culture medium generally in great excess, medium
exchange typically needed every 48 h to once a week (Freshney,
2010).
Medium turnover is faster and needs to be assessed for every cell line and
device. Some reports indicate increased glucose consumption (Paguirigan
and Beebe, 2009).
Proliferation Doubling time of immortalized cell lines varies but is typically
between 18 and 24 h.
Proliferation rates need to be re-evaluated when cells are cultured in
microﬂuidic devices. Some studies report reduced proliferation (Paguirigan
and Beebe, 2009).
pH regulation Culture medium is buffered at pH 7.4 with bicarbonate if CO2 levels
are kept at 5%. HEPES is also a common buffer that is not as
sensitive to CO2.
PDMS is more permeable to CO2 than to O2 or N2 (Mark, 1999). Care must
be taken to ensure that dissolved gas levels within chambers are as
expected.
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They reported that liver spheroids cultured in their co-culture
system showed improved albumin and urea secretion as well as
increased enzymatic activity over spheroids cultured in conven-
tional monocultures. In addition to the devices mentioned above,
microﬂuidic devices mimicking the organ speciﬁc architecture and
functionality of lung (Long et al., 2012), heart (Grosberg et al.,
2011), microvascular networks (Zheng et al., 2012) and a blood
brain barrier (Booth and Kim, 2012) have been developed. Efforts
to inter-connect some of the “organ-on-a-chip” systems to pro-
duce micro total bioassay systems for pharmacological studies are
already under way (Imura et al., 2012). This promising technology
will provide a valuable tool to predict whole-body responses to
drugs and other pharmacological challenges (Sung et al., 2014).
Only a very limited selection of the literature on miniaturiza-
tion, integration, automation and parallelization of cell culture
processes in microﬂuidic devices has been treated in this section.
However, from this selection it is clear that microﬂuidic cell
culture devices can have signiﬁcant advantages over macroscopic
cell culture systems. As is evident from Table 1, different micro-
ﬂuidic cell culture devices have distinct beneﬁts. As there is great
versatility with regard to the possible designs of a microﬂuidic cell
culture device, undoubtedly new advantages of these devices will
emerge over macroscopic cell culture. Although microﬂuidic cell
culture does have signiﬁcant advantages, it is important to be clear
about the remaining challenges in order to manage expectation
among end users. In the next section we discuss what we perceive
are the main challenges associated with microﬂuidic cell culture.2 Base: polyvinylsiloxane (60–90%), polyalkylalkenylsiloxane (10–30%), and
ethylbenzene <( 1%). Curing agent: polyvinylsiloxane (30–60%), modiﬁed silica
(SiH) (30–60%), octamethylcyclotetrasiloxane <( 1%) and toluene <( 1%).
3 Base: dimethylsiloxane oligomers with vinyl-terminated end groups >( 60%),
silica ﬁller (dimethylvinylated and trimethylated silica, 30–60%), tetra(trimethylsi-
loxy) silane (1–5%) and ethylbenzene <( 1). Curing agent: a cross-linking agent
(dimethyl methylhydrogen siloxane, 40–70%) and an inhibitor (tetramethyl tetra-
vinyl cyclotetrasiloxane 1–5%).3. Challenges of microﬂuidic cell culture
Although microﬂuidic cell culture provides great ﬂexibility
with respect to experimental design, moving cells from a macro-
scopic culture environment of dishes, ﬂasks and well-plates to
microﬂuidic cell culture requires revision of culture protocols.
Several unique factors distinguish microﬂuidic from macroscopic
cell culture, such as different culture surfaces, reduced media
volumes, and vastly different rates of, and methods for, medium
exchange. Careful evaluation of these differences needs to be
completed before experiments are translated between these plat-
forms. Table 2 compares key parameters of macroscopic and
microﬂuidic cell cultures. Despite a growing number of microﬂuidic
cell culture devices, efforts to compare cellular behavior in micro-
ﬂuidic devices versus macroscopic cell culture have been few andin some respects contradictory. This is likely a result of the large
variety of device designs and parameters, as well as cell-speciﬁc
responses to microﬂuidic culture. Table 3 summarizes some
selected publications that contain general information on micro-
ﬂuidic cell culture systems, their parameters and, if possible, how
those systems compare to macroscopic cultures on polystyrene or
glass. In this section the focus is on some of the intrinsic
differences between macroscopic cell culture in Petri dishes, ﬂasks,
and well-plates on one hand, and microﬂuidic culture platforms
on the other. The intention is to aid researchers wishing to enter
the growing ﬁeld of microﬂuidic cell culture.
3.1. Culture materials: polydimethylsiloxane versus polystyrene
Silicone is a synthetic polymer whose backbone is a repeating
chain of Si–O molecules with various organic groups attached to
the silicon. The silicone termed polydimethylsiloxane [(CH3)2Si–
O], abbreviated PDMS, has two methyl groups attached to the
silicon. As with all silicones, PDMS polymers will cross-link, with
the addition of a curing agent containing a catalyst, usually
platinum. PDMS has been widely used to produce microﬂuidic
devices. It can be easily molded to create complex ﬂuidic circuits,
using soft lithography techniques, making prototyping relatively
simple and cost effective. Some characteristics of PDMS, such as
gas permeability, optical transparency, and ﬂexibility also make it
appealing for cell culture devices. In addition, it is generally
regarded as inert, non-toxic, and fully bio-compatible. The fabrica-
tion of PDMS devices involves mixing the PDMS elastomer base
with a curing agent, pouring it into a mold and heating to
accelerate the curing process. The cured PDMS can then be
permanently bonded to a glass or plastic slide by plasma or thermal
bonding. The duration of this process depends on device design
and PDMS type. Two types of PDMS are commonly used by
researchers to fabricate microﬂuidic chips: RTV-615 from Momen-
tive Materials2 and Sylgard 1843 from Dow-Corning. Both manu-
facturers report the use of irritants such as ethylbenzene and
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S. Halldorsson et al. / Biosensors and Bioelectronics 63 (2015) 218–231224xylene in small amounts in their PDMS blends. If and how this
may affect cells cultured on cured PDMS is unknown. Sylgard 184
is more commonly used for fabrication of cell culture devices.
Despite the wide range of PDMS based microﬂuidic cell culture
devices that have been reported to date, few compare cellular
proliferation in the device to macroscopic culture. Some consider
PDMS to be bio-compatible and not cytotoxic, based on the use of
medical grade PDMS within long term medical device implants
(Hassler et al., 2011; Nag and Banerjee, 2012) and reports of
growth of a variety of cell lines on various formulations of PDMS.
However, this does not imply that all types of cells will grow on all
formulations of PDMS in the same way that they do on macro-
scopic culture plastics, such as polystyrene. Others regard the
often cited biocompatibility of PDMS to be “something of a
misnomer” (Sackmann et al., 2014).
There have been reports of artifacts arising from chemical and
physical interactions between in vitro cultures and certain for-
mulations of PDMS. One of the ﬁrst studies on cellular attachment
and proliferation on PDMS (and many other synthetic surfaces)
was performed by Ertel et al. in 1994. They found that culturing
cells on an untreated PDMS (“NIH reference material”) surface
induced rapid and high levels of cell death on two types of
ﬁbroblasts (3T3 and BHK). This effect could be blocked by treating
the PDMS culture surface with serum or a concentrated protein
solution. As PDMS is hydrophobic, cellular attachment to native
PDMS surfaces may be increased with treatment to reduce its
hydrophobicity, or coating the surface with proteins that facilitate
cellular attachment. Lee et al. (2004) studied the compatibility of
four mammalian cell lines (HUAEC primary endothelial cells; 3T3
ﬁbroblast cell line; MC3T3-E1 osteoblast cell line; HeLa trans-
formed epithelial cells) on PDMS (Sylgard 184) surfaces with
different ratios of PDMS base and curing agent, with or without
extraction of low molecular weight components with organic
solvents, and with or without oxidizing the surface. All surfaces
were coated with ﬁbronectin to facilitate cellular attachment. All
of the cell lines tested attached and proliferated on PDMS to some
extent and sometimes at rates comparable to polystyrene. How-
ever, the cells tested seemed to have different preferences for
PDMS formulations. For example, MC3T3-E1 osteoblasts attached
and grew on native, ﬁbronectin coated PDMS, at rates comparable
to polystyrene. Solvent extraction of unbound PDMS oligomers
and oxidation reduced attachment and severely impaired prolif-
eration. Excess curing agent (10 : 3Base CA instead of 10 : 1Base CA) had
little effect either on attachment or proliferation. However, HeLa
cells showed poor attachment and proliferation on native PDMS,
or PDMS with excess curing agent, but attachment to solvent
extracted and oxidized PDMS was comparable to polystyrene.
Wang et al. (2010) found that Caco-2 cells showed reduced attach-
ment and little or no proliferation on PDMS with excess curing
agent (5 : 1Base CA instead of 10 : 1Base CA). Taken together, the results
from these studies show that PDMS is capable of sustaining
growth of different cell lines, provided that the formulation and
surface treatment are optimized for each cell line.
Incomplete curing of PDMS leaves uncross-linked oligomers
within the material that can leach out and contaminate the culture
medium. Indeed, when deionized ultra-ﬁltered water was incu-
bated within a PDMS-based microﬂuidic channel for 24 h and
analyzed with matrix-assisted laser desorption/ionization time-of-
ﬂight mass spectrometry, a continuous range of uncrosslinked
PDMS was detected despite efforts to extract uncrosslinked PDMS
with ethanol in a Soxhlet extractor overnight (Regehr et al., 2009).
The same study also showed that PDMS oligomers were detectable
in the membranes of mouse mammary ﬁbroblasts cultured in
PDMS (Sylgard 184) microﬂuidic channels for 24 h. The effect of
PDMS incorporation into cellular membranes of cultured cells is as
S. Halldorsson et al. / Biosensors and Bioelectronics 63 (2015) 218–231 225yet unknown. To reduce the amount of uncrosslinked polymers
left in the material, care must be taken to allow curing to run to
completion. This should be done as per instructions provided by
each manufacture of PDMS as different formulations may cure at
different rates. It should be noted that in this experiment the
PDMS was cured for only 2 h, which may have increased the
possibility of uncrosslinked PDMS in contact with the cells.
The surface area-to-volume (SA/V) ratio in macroscopic culture
is roughly 0.5 mm2 to μ1 L of medium and this ratio holds true
from 96-well plates to larger culture ﬂasks. In contrast, the surface
area-to-volume ratio varies greatly from one microﬂuidic device to
the next. The surface area in direct contact with culture medium in
microﬂuidic culture devices can be fully or partially composed of
PDMS. Paguirigan and Beebe (2009) published an extensive study
on phenotypic changes of mouse mammary ﬁbroblasts cultured in
macroscopic polystyrene culture wells versus open unspeciﬁed
PDMS microwells that had the same SA/V ratio as macroscopic
culture, or closed PDMS microchannels that had 4 times higher SA/
V. They found that proliferation was impaired in the microchan-
nels, which could not be mitigated with increased glucose or
serum supplementation. In addition, they observed several distinct
cell cycle progression problems in cells cultured in the micro-
channels. Their conclusion was that PDMS surface area to media
volume (SA/V )PDMS , a ratio that can be as high as 30 mm
2 μPDMS/ L
medium in some microﬂuidic cell culture devices (Gomez-Sjoberg
et al., 2007; Millet et al., 2007; Lee et al., 2006; Chen et al., 2011), is
a determining factor for cellular proliferation and behavior. As this
ratio increases, changes in baseline functions such as proliferation
and metabolism become more pronounced.
Millet et al. (2007) examined primary mammalian neuron
culture and differentiation at low densities in open versus closed
microﬂuidic channels. They found that open channels, with large
media volumes, could support neuron growth for at least 8 days,
while neurons did not survive in closed channels made of native
PDMS (Sylgard 184). Autoclaving the PDMS to drive polymeriza-
tion to completion, or extraction of uncrosslinked polymers with
organic solvents, improved neuron growth in the closed channels,
although it did not reach the same level of growth as in the open
channels. It should be noted that these channels were constructed
of a PDMS roof and side-walls mounted onto a glass coverslip, so
that the culture surface was poly-D-lysine coated glass, not PDMS.
Wlodkowic et al. (2009) compared growth rates of three different
cell lines (2 human leukemic cell lines, K562 and U937 and a
human tumor cell line, U2OS), in a PDMS (Sylgard 184) based
microﬂuidic cell culture device versus in macroscopic polystyrene
culture plates. They found no adverse effects on cell viability or
growth after 48 h of culture (Wlodkowic et al., 2009).
Lopacinska et al. (2013) studied the use of polymethyl metha-
crylate (PMMA) as a culture substrate. They compared the bio-
compatibility of PMMA alone, polystyrene alone or a layer of PDMS
(Sylgard 184) underneath a perforated layer of PMMA (PMMA–
PDMS), with respect to PC12 (adrenal phaeochromocytoma) cell
growth and PC12 differentiated into neuronal-like cells. They
observed that for non-differentiated cells there was little difference
in gene expression among polystyrene, PMMA and PMMA–PDMS,
while there were signiﬁcant differences between the gene expres-
sion proﬁles of PC12 cells differentiated on PMMA versus PMMA–
PDMS surface.
Hydrophobic molecules, less than approximately 500 Da, are
absorbed into PDMS (Gomez-Sjoberg et al., 2010), which compli-
cates the interpretation of some studies. Liu et al. (2010) compared
mouse embryonic ﬁbroblast growth in microchannels on different
surfaces and reported that attachment and cell spreading were
substantially impaired on PDMS, compared to polystyrene.
Embryonic stem cell differentiation was also impaired when thecells were cultured on PDMS rather than on polystyrene or glass.
In these experiments, differentiation of embryonic stem cells was
induced with retinoic acid, a small (300 Da) hydrophobic molecule
widely used to induce differentiation in various cell types.
The differences reported by these studies suggest that the
viability of cells cultured within a microﬂuidic device depends both
on the particular cell type being cultured and on the particular
protocol for fabricating the material, e.g., PDMS, within the device.
This underlines the necessity of evaluating cell growth, morphol-
ogy and viability of every cell line, relative to macroscopic culture,
when it is introduced to a particular microﬂuidic culture device.
3.1.1. Surface treatment and coating
The majority of cultured mammalian cells grow as monolayers
on an artiﬁcial substrate. The surface must be correctly charged to
allow cellular attachment and spreading. Polystyrene, by far the
most common surface for cell culture, is hydrophobic in its native
state and must be rendered hydrophilic before it permits cell
adhesion. UV treatment or oxidizing with oxygen plasma is
commonly used to reduce hydrophobicity of polystyrene, making
it more appropriate for cell culture. Flasks and well-plates whose
surfaces have been oxidized in this way are referred to as “tissue
culture treated”. The surface of native PDMS is also hydrophobic
and must therefore be speciﬁcally treated prior to cell culture to
facilitate attachment and growth. A number of different methods
have been developed to reduce hydrophobicity and coat PDMS
surfaces for enhanced cell attachment.
Oxygen plasma and UV treatment are commonly used to
activate synthetic surfaces (Wong and Ho, 2009), thus reducing
the surface hydrophobicity. Recently, van Midwoud et al. (2012)
compared treatments of different cell culture plastics and PDMS
(Sylgard 184). They measured how the hydrophobicity of different
materials was reduced by an oxidizing treatment and how stable
the treatment was. The hydrophobicity of polystyrene was quickly
reduced with either UV or oxygen plasma treatment and the
polystyrene surface remained relatively hydrophilic for the dura-
tion of the experiment (4 weeks). On the other hand, although the
hydrophobicity of PDMS could be reduced with these treatments,
the PDMS surface returned to its hydrophobic state within 1 week,
a process known as hydrophobic recovery (Eddington et al., 2006).
This effect is due to low molecular weight uncrosslinked PDMS
polymeric side-chains diffusing from the bulk to the surface, thus
returning it to its hydrophobic state (Chen and Lindner, 2007).
Although the hydrophobic recovery of PDMS can be attenuated to
some extent (Eddington et al., 2006), this limits the feasibility of
oxidizing the PDMS surface for cell culture, particularly for long-
term culture experiments or when treated devices are stored
before use.
Another approach to reduce hydrophobicity is to coat the PDMS
culture surface to promote cellular attachment and proliferation,
either by coating with charged molecules or extracellular matrix
proteins such as ﬁbronectin, collagen or laminin. The strong
hydrophobic nature of PDMS causes it to interact with polar
substrates either through hydrogen bonding or through polar–polar
interactions. Substrates containing methyl or alkyl groups can also
interact with PDMS due to van der Waals forces (Kuncova-Kallio
and Kallio, 2006). This means that proteins will adhere to an
untreated PDMS surface depending on their structure and surface
charge. Wang et al. (2010) studied the effects of different coatings
on attachment and proliferation of Caco-2 cells. Incubating the
PDMS (Sylgard 184) culture surface with cellular growth medium
containing fetal bovine serum was sufﬁcient to promote attach-
ment and proliferation on oxidized PDMS. Adsorbing extracellular
matrix (ECM) proteins such as ﬁbronectin or collagen onto native
PDMS also facilitated attachment and proliferation.
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SUM159 and MDA-MB-468 breast cancer cell lines on PDMS (RTV
165) with varying stiffness, coated with ECM proteins and bovine
serum albumin (BSA). Native or oxidized PDMS proved to be
unfavorable for cellular attachment while collagen and ﬁbronectin
coating greatly improved cellular attachment, regardless of PDMS
stiffness. Although BSA coating also improved attachment, cellular
morphology was altered from spindle-shaped to round, indicating
weaker adherence. Interestingly, these researchers observed an
enrichment of cells expressing cancer stem-cell markers after
2 weeks of culture on BSA coated PDMS. They conclude that coating
PDMS with ECM proteins or BSA to facilitate attachment can
provide a suitable substrate for culturing breast cancer cells but
the phenotypic equilibrium of these cells may be altered in
response to cell-to-surface interactions.
Another possible way to treat PDMS surfaces is to coat them
with charged molecules such as poly-D-lysine. The amino group on
the end of each lysine develops a net positive charge which makes
it hydrophilic and may enhance electrostatic interaction between
negatively charged ions in the cell membrane (Wang et al., 2010).
To screen for cellular attachments and proliferation on different
surface coatings and media compositions, Hattori et al. (2011)
devised a microenvironment array chip containing an 88 array
of perfusion chambers that can be independently surface treated
with up to four different extracellular matrix proteins (columns)
and perfused with four different media compositions (rows). The
96 chamber microﬂuidic cell culture device designed by Gomez-
Sjoberg et al. (2007) offers the possibility of coating each of the
chambers independently through 16 inputs and feeding with up
16 different media compositions. Devices such as these can aid
researchers in devising the optimal surface treatment and feeding
for any cell type that is to be cultured in a PDMS based microﬂuidic
environment.
Many microﬂuidic devices contain elaborate medium ﬂow
circuits for creating gradients and mixing before the medium enters
the culture area. Through these ﬂow circuits, the medium ﬂows
over a large surface of PDMS where proteins and hydrophobic
analytes in the medium may attach to the free hydrophobic sites of
the PDMS channel (Zhou et al., 2012). This can lead to unwanted
cellular attachment in the ﬂow channels or non-speciﬁc protein
adsorption from the culture medium. To overcome this, various
surface treatments have been developed to modify the surface and
prevent its interaction with proteins (Wong and Ho, 2009). Among
the most commonly used surfactants are poly(ethylene oxide)-
terminated triblock polymers, such as ®Pluronic which are able to
form a stable adsorbed layer on the hydrophobic PDMS surface,
thus preventing non-speciﬁc protein adsorption (Wong and Ho,
2009). Yang et al. (2010) developed a method where native PDMS
was coated with polysaccharides using a photocatalyzed surface
modiﬁcation method. They found that carboxymethyl cellulose
coating repelled both positively and negatively charged proteins
while retaining the ability to support cell attachment, proliferation
and migration.
3.2. Absorption of hydrophobic molecules
The hydrophobic and porous nature of PDMS enables small
hydrophobic molecules to diffuse from the culture medium into
the bulk polymer. It has been demonstrated that Nile Red, a small
hydrophobic ﬂuorescent dye, is absorbed into PDMS surrounding a
microﬂuidic channel in a matter of seconds, and the ﬂuorescent
signal was retained in the PDMS despite multiple washes (Toepke
and Beebe, 2006). Regehr et al. (2009) demonstrated that when
cell culture medium containing 1 nM estrogen was incubated in
microﬂuidic channels, over 50% of the estrogen diffuses from themedium into the PDMS during the ﬁrst hour of incubation. After
24 h, 90% of the estrogen had diffused into the PDMS. Recently,
Wang et al. (2012) measured the extent of absorption of ﬁve
different markers routinely used for in vitro cellular assays. They
discovered a relationship between the logarithm of the octanol/
water partition coefﬁcient (logP) of the markers and the degree of
leaching into the PDMS. A logP threshold of ≈2.5 separated the
markers that exhibited low absorption (≤25% after 4.5 h) and those
that exhibited high absorption in PDMS (≥75% after 0.5 h).
Although logP values for many chemical compounds are known,
the exact values will depend on experimental conditions
(Haraldsdóttir et al., 2012). Most media components such as amino
acids, glucose and pyruvate have low logP values (4 to 1) and
should therefore exhibit low absorption into PDMS. However, fat-
soluble vitamins such as retinoic acid and calciferol, and lipid
derived hormones, have high logP values ≥( 6) and will therefore
be quickly absorbed into the bulk PDMS of the culture chip. Cell
culture experiments that rely on these vitamins or hormones for
differentiation or stimulation will need to be speciﬁcally optimized
for microﬂuidic culture in PDMS devices. Some treatments have
been reported in the literature for reducing the absorption of small
molecules into PDMS, such as sol-gel and borosilicate glass coating
(Gomez-Sjoberg et al., 2010; Abate et al., 2008; Orhan et al., 2008).
Although these treatments greatly reduce the absorption of small
hydrophobic molecules into PDMS, they also change the surface
properties of PDMS and therefore should ﬁrst be thoroughly tested
for their inﬂuence on cells in macroscopic culture.
3.3. Oxygen, osmolarity and pH
A valuable property of PDMS for microﬂuidic cell culture
devices is its permeability to gases. This allows for permeation of
ambient CO2 and O2 through the material to buffer the culture
medium and supply the necessary oxygen. However, PDMS is also
permeable to water vapor, which can cause drying problems in
devices where the media volume is small compared to the surface
area. Evaporation of even small amounts of water from the
medium can cause a signiﬁcant shift in medium osmolarity. Most
cell lines can tolerate osmolarity ranges from 260 to 320 mOsm/kg
but shifts in osmolarity during culture should be avoided
(Freshney, 2010). Heo et al. (2007) showed that evaporation in
culture chambers containing 500 nL of medium through a thin
– μ(120 400 m) PDMS membrane caused a rapid shift in osmolarity
that was sufﬁcient to kill human endothelial cells in only 25 min.
Blau et al. (2009) fabricated culture vessel lids, of 1 mm thick
PDMS, and reported reduced evaporation and stabilized medium
osmolarity in long-term cell cultures.
The optimal pH for most cultured cells lies in a narrow range
around 7.4 (Freshney, 2010). This may deviate slightly from one
cell line to another, but most commercially available media are
designed to keep pH close to 7.4. Cellular respiration produces
carbon dioxide that dissolves in the medium to produce carbonic
acid, which combined with acidic metabolic byproducts such as
lactate, tend to acidify the medium. Therefore cell culture media
needs to be buffered to keep pH within a physiological range. Cell
culture in ﬂasks or dishes is generally performed in incubators that
allow control of ambient CO2. Lids or caps are kept un-tight or
contain ﬁlters that allow diffusion of gas between the culture and
the surrounding air and the necessary CO2 exchange between the
medium. As PDMS is permeable to gas, control of the partial
pressure of CO2 in ambient air can be used to buffer media pH. The
partial pressure of ambient CO2 required to maintain pH within a
certain physiological range is also dependent on whether the fresh
culture media also contains a buffer, such as sodium bicarbonate.
S. Halldorsson et al. / Biosensors and Bioelectronics 63 (2015) 218–231 227HEPES can also be used to buffer cell culture media at 7.4.
HEPES can maintain physiological pH without the need for control
of ambient carbon dioxide and might be used when culturing cells
in microﬂuidic devices outside of incubators. Some considerations
are necessary when using HEPES to buffer culture media instead of
bicarbonate. HEPES is light sensitive and is reported to produce
hydrogen peroxide when exposed to ambient or ﬂuorescent light,
which may have adverse effects on the culture (Bowman et al.,
1985). HEPES buffered media should therefore be kept in the dark
as much as possible. This point is especially relevant for micro-
ﬂuidic cell culture with transparent material, such as PDMS,
outside of a dark incubator. Addition of HEPES to culture medium
will also cause a shift in osmolarity so careful evaluation and
testing should be carried out if it is to supplement complete
media.
Oxygen is necessary for cellular respiration in vivo. However,
the oxygen requirements of cells cultured in vitro vary greatly as
many cell lines rely primarily on glycolysis rather than aerobic
respiration for energy production. Primary cultures, particularly
from late stage embryos or adults, typically require more oxygen
than transformed cell lines. Other cells, for example mesenchymal
stem cells, proliferate faster and longer and maintain their undif-
ferentiated characteristics better under hypoxic conditions (Ma
et al., 2009). Rat embryonic neurons and neuronal stem cells have
been reported to grow just as well in anoxic medium as normoxic,
provided that the glucose in the medium is sufﬁcient (Wohnsland
et al., 2010). During normoxic conditions, these cells will fully
metabolize glucose via glycolysis and oxidative phosphorylation. If
cultured in an anoxic environment, glucose consumption increases
about 5-fold and lactate production increased about 10-fold with
no marked reduction in viability. Apart from a direct effect on cell
viability, oxygen levels can also greatly affect cellular behavior,
morphology and differentiation (Mannello et al., 2011; Panchision,
2009).
In macroscopic culture, oxygen and CO2 diffusion from the air
inside the incubator into the culture medium is usually considered
sufﬁcient to supply the cells with the necessary oxygen amount for
growth and proliferation and adequate medium buffering
(Freshney, 2010). Incubation of microﬂuidic culture devices gener-
ally takes place in either a standard laboratory incubator or
mounted onto a live-cell imaging station or bioreactor. In any case,
ambient CO2 levels need to be accurately controlled to maintain
the correct pH. The ratio of media-to-cell volume tends to be lower
with microﬂuidic cell culture, therefore, especially if no bicarbo-
nate or HEPES are added to the media, one must ensure that
permeation of O2 and CO2 can occur at rates sufﬁcient for aerobic
respiration and buffering of media pH, respectively. PDMS is highly
permeable to gases and allows diffusion of CO2 and oxygen into
the medium inside microﬂuidic channels, supplying the culture
with oxygen, removing carbon dioxide produced by cellular
respiration and maintaining physiological pH. Passive permeation
of oxygen through PDMS is generally assumed to be sufﬁcient for
supply at a rate sufﬁcient for aerobic respiration. How the thick-
ness of PDMS or surface coating for cell adhesion will affect gas
exchange is not clear. For example, native PDMS is highly oxygen
permeable, but the permeability is subject to change when
proteins are adsorbed on it or when the surface is modiﬁed by
plasma oxidation, as is common in the construction of microbior-
eactors (Mehta et al., 2007). Kim et al. state that thin PDMS
membranes (∼ μ100 m thickness) can be used for gas exchange in a
microﬂuidic perfusion culture (Kim et al., 2007).
In thin-walled PDMS culture channels, containing metaboli-
cally active rat hepatocytes, Ochs et al. (2014) report that oxygen
was readily replenished (to approximately 16%) by the environ-
ment but that the same cells cultured in 5 mm thick PDMS devicesresulted in oxygen levels of to approximately 11.5%. The same
study provides calculations for medium perfusion rates necessary
to maintain stable oxygen levels within microﬂuidic culture
channels, based on device dimensions, diffusion rates and oxygen
uptake rates of the cells. Gases have different permeability and
solubility in PDMS than in water (Mark, 1999). This leads them to
fractionate within the PDMS so the real concentration of CO2 and
oxygen inside the chip may be different from that in the air around
it. To better regulate on-chip oxygen levels or create oxygen
gradients, Thomas et al. (2011) developed a microﬂuidic culture
device where precisely oxygenated water is continuously perfused
through channels adjacent to cell culture chambers, allowing rapid
control of on-chip oxygen levels within physiological ranges while
at the same time minimizing evaporation from the culture
chambers.
Novel methods to accurately measure pH and oxygen levels
inside microﬂuidic cell culture chambers in real time are necessary
as standard laboratory pH and oxygen probes are too large to work
with such small media volumes. In addition, the culture medium
in most microﬂuidic culture chambers is closed off within PDMS,
making direct measurement challenging. Methods utilizing a
ratiometric pH sensitive dye and oxygen sensitive ﬂuorescent
probes such as BCECF and RTDP to measure perturbations inside
microﬂuidic channels and chambers have been developed, but
they rely on modifying the culture device or medium composition
with potentially harmful effects to the cells cultured within the
device (Han and Burgess, 2010; Lee et al., 2008). Recently,
Magnusson et al. (2013) developed a highly accurate and precise
method to indirectly measure microﬂuidic chamber pH by mea-
suring the shift of light absorption by phenol red as a function of
pH. Contrary to previously reported methods, this method
requires only a standard cell culture medium, standard microﬂuidic
device design and a standard laboratory microscope with a
suitable ﬁlter. Real time monitoring is necessary for proper quality
control of conditions within microﬂuidic cell culture chambers.
Different methods are used to supply fresh media to micro-
ﬂuidic cell cultures. Syringe pumps are commonly used to ﬂow
media directly into culture lines or chambers. Fresh medium can
also be supplied by pressurizing media vials connected to culture
lines or chambers with air and using on-chip valves to precisely
control ﬂow in and out of the device (Gomez-Sjoberg et al., 2007).
Attention must be paid to the composition of the air used to
pressurize these media vials. For example, if the medium contains
bicarbonate buffer and the media vials are pressurized with
ambient air (0.039% CO2 by volume), the pH of the medium will
increase in the vials before it enters the device. Therefore, media
vials should be pressurized with air containing the correct per-
centage of CO2 and O2 in order to keep pH and dissolved oxygen at
physiological levels.
3.4. Nutrient consumption and medium turnover
In contrast to macroscopic cell culture where medium is
typically stagnant in culture ﬂasks or wells, relying on excess
amounts of nutrients in the culture medium to feed cells over a
number of days, microﬂuidic systems can be designed for perfu-
sion culture, where medium continuously ﬂows through the
culture channels and chambers. This method can create a more
realistic culture environment by keeping nutrients and other
important media factors constant by continuously supplying fresh
media and removing waste products (Kim et al., 2007). Continuous
perfusion also offers unique opportunities to create chemical
gradients within the cell culture, which are difﬁcult to achieve with
macroscopic culture methods (Kim et al., 2007; Chung et al.,
2005). However, culturing cells under ﬂow has its own challenges.
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glucose, glutamine and amino acids, and produce metabolic waste,
such as CO2 and lactate. Most microﬂuidic culture devices have a
high number of mammalian cells to media volume, which better
simulates in vivo cell density. If this ratio is 50 times higher in a
microﬂuidic cell culture device than in macroscopic culture, one
can assume that metabolites will be depleted and wastes will build
up 50 times faster. Medium in a macroscopic culture is generally
changed every 2–4 days to replenish nutrients and remove waste.
With the aforementioned ratio, this corresponds to total media
exchange in a microﬂuidic chamber every 1–2 h.
Paguirigan and Beebe (2009) found that the baseline glucose
consumption per cell of mouse mammary ﬁbroblasts was three to
four times higher in a microﬂuidic culture device than in macro-
scopic culture. Due to the high cell number to media volume ratio
in microﬂuidic devices, careful validation experiments and feeding
schedule calibrations are necessary for every device and cell line.
Yu et al. (2007) did an extensive study on medium exchange rates,
supplementation and seeding density in microﬂuidic channels
versus macroscopic culture. Among their ﬁndings was that increas-
ing the medium exchange frequency from 12 h to 1 h resulted in
slower proliferation of normal mouse mammary (NMuMG) cells in
both macroscopic culture and PDMS micro channels. Decreasing
the medium change frequency from 1 to 4 h had a beneﬁcial effect
on cell growth in both platforms, although cell proliferation in
micro channels was higher. They concluded that build-up of
endogenous growth factors plays a critical role in cell growth. These
soluble signaling molecules need to reach a certain concentration
in the medium before growth is promoted. Due to the high cell
number-to-media volume ratio of most microﬂuidic channels and
chambers, the critical level of soluble factors in the cellular
microenvironment can be reached more quickly. A balance is
necessary between, on one hand, the rate of media replacement
required for replenishment of nutrients, and on the other, the need
to keep the concentration of endogenous growth at effective
levels.
With computational modeling and experimental testing,
Giulitti et al. (2013) optimized medium replacement strategies for
long-term culture of mouse myoblasts (C2C12), human ﬁbroblasts
(HFF) and mouse embryonic stem cells (mESCs) in PDMS (Sylgard
184) microchannels. They examined constant ﬂow rates, as well as
periodic replacement of medium, and found that slow, continuous
perfusion had deleterious effects on their cultures, especially
downstream while fast, periodic replacement of the same media
volumes resulted in uniformally healthy growth of all cell types
within the channels. This was attributed to heterogeneous dis-
tribution of nutrients (higher concentration upstream) versus
endogenous factors and waste (higher concentrations downstream)
in slowly perfused culture channels. They conclude that medium
delivery strategies are extremely relevant for proper maintenance
of cell homogeniety, viability and behavior in microﬂuidic cell
culture.
Another important factor to consider when exposing cells to a
perfusion ﬂow in microﬂuidic channels is shear stress. When rat
mesenchymal stem cells, adherent to a microﬂuidic cell culture
chamber, were exposed to sufﬁcient ﬂow induced shear stress
(1.3 N m2), Zheng et al. (2012) reported “contraction and re-
spread” process, whereby cells contracted during the initial 20–
30 min and re-spread in a similar period. While the device
fabricated by Zheng et al. (2012) was designed to mimic the ﬂow
induced shear stress typical of blood vessels, it is important to
recognize the morphological response of cells to shear stress and
eliminate it when not desired. Different strategies to minimize the
effect of sheer stress on culture stability have been published.
Kolnik et al. (2012) developed a cell trapping system to load cellsinto isolated culture chambers using an on-chip vacuum and
evacuating air through the PDMS. While medium continuously
ﬂowed past the culture chambers, the cells were not in the direct
path of ﬂow, while diffusion replenished nutrients into and
removed waste from the culture chambers.
Su et al. (2014) characterized the effect of various culture
parameters on cell stress in human embyronic kidney cells cultured
in PDMS (Sylgard 184) microchannels, by measuring the expres-
sion of a key chaperone gene involved in the unfolded protein
response. Without replenishing media, cell stress was signiﬁcantly
higher at 48 h than at 24 h post-seeding, while media replenish-
ment at 21 h reduced stress at 24 h. However, Su et al. also report
that increased frequency of media replacement (6–12 h intervals)
leads to “abnormal cellular morphology”, which might be related
to the “contraction and re-spread” process observed by Zheng
et al. (2012). Su et al. (2014) also provide evidence suggesting that
increasing the concentration of foetal bovine serum in media can
alleviate stress in some cell lines.4. Conclusions
The development of microﬂuidics over the past decade has
been fast. Microscale bioreactors and analysis systems have grown
in ever increasing numbers and complexity, offering new insights
into complex cellular behavior. Microﬂuidics has brought the
ability to custom tailor microenvironments, automate experimenta-
tion and couple cell culture directly to high throughput analysis
systems. As enticing as these new advances may be, there are still
hurdles that arise when an established culture platform is changed
from macroscale cultures on polystyrene to microﬂuidic devices
made of PDMS or other materials. Different cell types respond
differently when moved from macroscopic culture on polystyrene
to microﬂuidic culture on PDMS. Device designs are as diverse as
the cell lines cultured within them, making generalizations difﬁ-
cult. In addition, it is likely that negative results, such as sub-
optimal cell growth in a given device or other complications, may
be underrepresented in the literature.
Although PDMS has a number of properties that are beneﬁcial
for cell culture, such as transparency and gas permeability, it
should be kept in mind that the primary reason for using this
material in microﬂuidic cell culture devices is from the fabrication
perspective, namely, ease of prototyping and low cost (Berthier
et al., 2012). For decades, glass and polystyrene have been used for
macroscopic cell culture and they have been thoroughly studied
and characterized in that respect. Indeed, the majority of new
published data on in vitro cell biology is still based on cells
cultured on these materials. When cell culture is moved from these
macroscopic platforms to PDMS based microﬂuidic devices, where
volumes are small, surfaces large in comparison to volume, and
feeding schedules different, cellular behavior may very well turn
out to be different. This makes direct comparison between
experiments performed on these platforms difﬁcult. This is not to
say that macroscopic cell culture is more reliable, only that
researchers should be aware of the fact that the transition may
not be straightforward, as most cell culture protocols in existence
have been optimized for macroscopic cell culture. As the ﬁeld of
microﬂuidic cell culture matures, we will undoubtedly see an
increase of standardized microﬂuidic devices. While design and
prototyping of novel devices are simpler and more cost efﬁcient in
PDMS, new production techniques such as microﬂuidic hot
embossing in polystyrene (Young et al., 2011) are likely to be
favored for mass production. Over the past decade, many compa-
nies have emerged that offer standard and customized microﬂui-
dic cell culture platforms, with chips fabricated from a wide range
Table 4
A selection of companies offering standard and customized microﬂuidic cell culture equipment.
Company Website Cell culture products Chip material
Aline www.alineinc.com Microslide Acrylic
BellBrook labs www.bellbrooklabs.com Microchannel plates Standard tissue-culture treated plastic
Cellix Ltd. www.cellixltd.com Chips, pumps, software, automated
platforms.
Acrylic, Topas
CorSolutions www.mycorsolutions.com Pumps, probe stations, probes, ﬂow
meters.
N/A
Cytoo www.cytoo.com Chips, plates, chambers Glass, Acrylic
Dolomite microﬂuidics www.dolomite-microﬂuidics.com Chips, interfaces, pumps, sensors,
valves.
Glass, fused silica, PDMS
Elveﬂow www.elveﬂow.com Pumps, ﬂow control software. N/A
Epigem www.epigem.co.uk Chips, gaskets, ferrules Polymethylmethacrylate (PMMA), Polyaryletherketone
(PEKK)
FlowJEM www.ﬂowjem.com Chips, interface accessories. Polycarbonate (PC), Cyclic oleﬁn polymer, Acrylic, PDMS
Fluidigm Corp. www.ﬂuidigm.com Chips, automated platforms. PDMS
Gradientech www.gradientech.se Chips (conc. gradient), software. Polymer
Merck Millipore www.emdmillipore.com Chips, pumps, software, automated
platforms.
PDMS
Microﬂexis www.microﬂexis.com Chips, interface accessories. Polycarbonate (PC), polystyrene & other polymers
Microliquid www.microliquid.com Chips, chip mounts. PDMS, PMMA, PC
Mimetas www.mimetas.com Chips, plates. Ordyl SY330
SIMTech Microﬂuidics Foundry www.simtech.a-star.edu.sg/smf Chips, interface accessories. Polymers, elastomer, epoxy
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disadvantages of PDMS, for instance compatibility with long term
culture (Trietsch et al., 2013).
To the researcher interested in entering the ﬁeld of microﬂuidic
cell culture, we offer the following general guidelines:
(1) Test the compatibility of any cell line intended to use for
microﬂuidic culture with various formulations of PDMS. A simple
experiment where a culture surface is coated with various for-
mulations of PDMS and cells seeded onto these surfaces should
quickly reveal any complications with cellular attachment, survival
or proliferation.
(2) To test for leaching of toxic or other unwanted species from
and medium component absorption into PDMS, one may incubate
fresh cell medium with PDMS (with sufﬁcient surface area),
separate the medium from the bulk PDMS, then add it to a well
characterized macroscopic cell culture and monitor for any
changes in response.
(3) Be aware that medium composition may have to be
adjusted to suit the device and cells. Small hydrophobic molecules
may be lost into the bulk PDMS and proteins, possibly important
growth factors, may be adsorbed to the PDMS surface or diluted by
too frequent media replacement. Medium buffering and oxygena-
tion may also need to be adjusted according to device dimensions.
(4) The relatively high ratio of cell number to medium volume
calls for more frequent feeding. Empirically test different sche-
dules so that medium is replenished when needed but not too
often. Endogenous soluble paracrine signaling factors may be
important for the viability of certain cell lines and may need time
to accumulate to sufﬁcient concentrations within the surrounding
medium.
(5) Pay attention to surface treatment of the PDMS. Poly-D-
lysine is a good, simple starting point for PDMS surface treatment
as it renders the surface hydrophilic and facilitates cellular
attachment. Different cell types require different surface treatments
for prolonged culture.
Microﬂuidic cell culture is highly interdisciplinary, relying on
the co-operation of engineers to design and fabricate new devices,
and cellular or molecular biologists to design and carry out
biologically relevant experiments. Due to the ever increasing
number of device designs, there is as yet little standardization in
the ﬁeld. In addition, many microﬂuidic cell culture devices rely on
complex external control systems that may be foreign to mostestablished cell culture laboratories. Therefore, biochemical
researchers should have strong ties to experienced engineers if
they hope to successfully enter the ﬁeld of microﬂuidic cell
culture. This being said, if cell biologists are aware of the intrinsic
factors that differ between macroscopic and microﬂuidic cell
culture, the latter nascent ﬁeld has the potential to be used to
investigate many hitherto under explored aspects of cell biology.Acknowledgments
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